Agnt expects Q3 revenue of $1.35B-$1.45B while tightening 2026 adjusted EBITDA to $50M-$60M (NASDAQ:AGNT)August 5, 2026
OrthoPediatrics projects $265M-$269M 2026 revenue and reiterates ~$25M adjusted EBITDA as it targets 2026 free cash flow break-even (NASDAQ:KIDS)August 5, 2026
Share Facebook Twitter LinkedIn Pinterest Email NVIDIA (NVDA) Yield Shares Purpose ETF declares CAD 0.20 dividend
Agnt expects Q3 revenue of $1.35B-$1.45B while tightening 2026 adjusted EBITDA to $50M-$60M (NASDAQ:AGNT)August 5, 2026
OrthoPediatrics projects $265M-$269M 2026 revenue and reiterates ~$25M adjusted EBITDA as it targets 2026 free cash flow break-even (NASDAQ:KIDS)August 5, 2026
Gilead outlines 2026 base business sales of $29.8B-$30.1B while raising HIV growth outlook to 9%-10% (NASDAQ:GILD)August 5, 2026
